ATTN LogoMenu
4ABTTier 5
기사 목록

ABBOTT LABORATORIES 4

0001644207-26-000012

View on SEC EDGAR

Abbott Laboratories Vice President and Controller John A. McCoy, Jr. had 52 shares withheld in a tax-related transaction and sold 27 common shares while retaining approximately 24.6K direct shares and a small indirect position in a profit sharing trust.

On September 1, 2026, Abbott Laboratories Vice President and Controller John A. McCoy, Jr. had 52 common shares withheld or disposed of in a transaction coded "F" at an implied price of $110.36 per share, consistent with a tax withholding or similar transaction related to an equity award, reducing his direct holdings to 24,576 shares. On September 2, 2026, he sold an additional 27 common shares at $109.54 per share in an open market sale (code "S"), further trimming his direct holdings to 24,549 shares. The filing also reports an indirect holding of 59 common shares in a Profit Sharing Trust, representing the balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2026. Based on the current stock price of approximately $108.10, the total value of the September 1 tax-related disposition is about $5,738, the September 2 sale is about $2,957, and his remaining direct holdings are worth roughly $2.65 million, with indirect trust holdings of about $6,379.

Filing Facts

CIK
1800
Ticker
ABT
Form
4
Source Type
sec
Accession
0001644207-26-000012
Alert Tier
5
ABBOTT LABORATORIES 4 | ATTN